A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
Glioblastoma is the most aggressive form of brain tumor originating from glial cells with a maximum life expectancy of 14.6 months. Despite the establishment of multiple promising therapies, the clinical outcome of glioblastoma patients is abysmal. Drug resistance has been identified as a major fact...
Main Authors: | Hera Hasan, Mohammad Afzal, Javier S. Castresana, Mehdi H. Shahi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/12/1578 |
Similar Items
-
Glioblastoma and MiRNAs
by: Swalih P. Ahmed, et al.
Published: (2021-03-01) -
Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis
by: Samantha Epistolio, et al.
Published: (2024-02-01) -
Temozolomide modulates the expression of miRNAs in colorectal cancer
by: Amany I. Alqosaibi, et al.
Published: (2021-01-01) -
The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development
by: Ekaterina Isachesku, et al.
Published: (2023-11-01) -
microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
by: Marianna Makowska, et al.
Published: (2023-02-01)